On June 13, 2014, Geron Corporation (NASDAQ:GERN), announced that the FDA removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis. Geron Corporation (NASDAQ:GERN), weekly performance is 3.55%. On last trading day company shares ended up $3.21. Analysts mean target price for the company is $4.13. Geron Corporation (NASDAQ:GERN), distance from 50-day simple moving average (SMA50) is 42.74%.
Glu Mobile Inc. (NASDAQ:GLUU)’s shares jumped 4.94% to $4.67. The company on June 25 announced the availability of Kim Kardashian: Hollywood on the App Store and Google Play. The game features Kim`s likeness, voice, and creative influence as she guides players on their journey to success in Hollywood. Glu Mobile Inc. (NASDAQ:GLUU), advanced 7..07% in last trading session and ended the day on $5.00. GLUU, Gross Margin is 66.30% and its return on assets is -17.40%. Glu Mobile Inc. (NASDAQ:GLUU), quarterly performance is 5.49%.
On June 12, 2014, Millennial Media, Inc. (NYSE:MM), recently announced to add Marc Theermann to their team, who will perform the role of Executive Vice President of Business Strategy. Working in MM team, Marc Theermann will report to President and CEO Michael Barrett. Millennial Media, Inc. (NYSE:MM), shares moved up 6.62% in last trading session and was closed at $4.99, while trading in range of $4.74 – 5.09. Millennial Media, Inc. (NYSE:MM), year to date (YTD) performance is -31.36%.
Depomed Inc (NASDAQ:DEPO), updated its FY14 earnings guidance on Thursday. The company provided EPS guidance of $0.00-$0.16 for the period, compared to the Thomson Reutersconsensus EPS estimate of $0.26, Analyst Ratings.Net reports. The company issued revenue guidance of $200-$215 million, compared to the consensus revenue estimate of $208.61 million. Depomed Inc (NASDAQ:DEPO), ended the last trading day at $13.90. Company weekly volatility is calculated as 2.81% and price to cash ratio as 3.87. Depomed Inc (NASDAQ:DEPO), showed a positive weekly performance of 3.27%.
On June 09, 2014, A deadline is coming up on June 10, in the lawsuit filed for investors of Imperva Inc (NYSE:IMPV), over alleged securities laws violations by Imperva Inc. Imperva Inc (NYSE:IMPV), net profit margin is -26.00% and weekly performance is 17.03%. On last trading day company shares ended up $26.18. Analysts mean target price for the company is $33.82. Imperva Inc (NYSE:IMPV), distance from 50-day simple moving average (SMA50) is 18.63%.